Cart
sales@molnova.com
Spiroxamine
CAS No. 118134-30-8
Spiroxamine ( —— )
Catalog No. M28102 CAS No. 118134-30-8
Spiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 45 | Get Quote |
|
| 10MG | 63 | Get Quote |
|
| 25MG | 102 | Get Quote |
|
| 50MG | 150 | Get Quote |
|
| 100MG | 223 | Get Quote |
|
| 500MG | 557 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSpiroxamine
-
NoteResearch use only, not for human use.
-
Brief DescriptionSpiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.
-
DescriptionSpiroxamine is a tertiary amine fungicide and an inhibitor of δ14 reductase and δ8→δ7 isomerase. Spiroxamine inhibits the growth of N. parvum, B. dothidea, D. seriata, and L. theobromae isolates from grape vines.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number118134-30-8
-
Formula Weight297.5
-
Molecular FormulaC18H35NO2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCCCN(CC)CC1COC2(CCC(CC2)C(C)(C)C)O1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Guardigli A, Chow W, Lefar MS. Determination of carbetamide residues and its aniline metabolite. J Agric Food Chem. 1972 Mar-Apr;20(2):348-50.
molnova catalog
related products
-
Cadazolid
Cadazolid is an oxazolidinone-type antibiotic, with activity against gram-positive bacteria, including Clostridium difficile.
-
SEA-0400
SEA0400 is a selective inhibitor of the Na+/Ca2+exchanger.
-
Tenilsetam
Tenilsetam is an endonuclease modulator; a nootropic agent and advanced glycation end product (AGE) inhibitor having potential for Alzheimer's disease (AD) treatment.
